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Gradations in extracellular regulated kinase (ERK)
signaling have been implicated in essentially every
developmental checkpoint or differentiation process
encountered by lymphocytes. Yet, despite intensive
effort, the molecular basis by which differences in
ERK activation specify alternative cell fates remains
poorly understood. We report here that differential
ERK signaling controls lymphoid-fate specification
through an alternative mode of action. While ERK
phosphorylates most substrates, such as RSK, by
targeting them through its D-domain, this well-stud-
ied mode of ERK action was dispensable for devel-
opment of gd T cells. Instead, development of gd
T cells was dependent upon an alternative mode of
action mediated by the DEF-binding pocket (DBP)
of ERK. This domain enabled ERK to bind a distinct
and select set of proteins required for specification
of the gd fate. These data provide the first in vivo
demonstration for the role of DBP-mediated inter-
actions in orchestrating alternate ERK-dependent
developmental outcomes.
INTRODUCTION
Differences in the extent of extracellular regulated kinase (ERK)
signaling play a critical role in virtually every major develop-
mental or differentiation process encountered by lymphocytes.
Indeed, ERK activity is required for ab T cell progenitors to tra-
verse the b-selection checkpoint, which restricts developmental
progression to progenitors with productively rearranged T cell
receptor (TCR) b loci (Fischer et al., 2005). Differential activation
of ERK has also been implicated in positive and negative selec-934 Immunity 41, 934–946, December 18, 2014 ª2014 Elsevier Inc.tion in the thymus, which shapes themature TCR repertoire of ab
T cells (Daniels et al., 2006; McNeil et al., 2005; Melichar et al.,
2013). After positive selection, CD4+ and CD8+ T cell lineage
commitment is determined by the duration of TCR signaling, as
codified in the kinetic signaling model. This model proposes
that adoption of the CD4+ T cell fate requires prolonged TCR sig-
nals, while adoption of the CD8+ T cell fate is dependent upon
transient signals, and the longevity of ERK signaling might play
an important role in this process (Singer et al., 2008). Finally, pe-
ripheral ab T cell effector fates are also influenced by the extent
of ERK signaling, because inhibition of ERK activity under T help-
er 17 (Th17) polarization conditions impairs Th17 differentiation
while favoring production of regulatory T (Treg) cells (Liu et al.,
2013). Differences in ERK activation have also been correlated
with separation of the ab and gd T cell fates, although the impor-
tance of these differences in controlling the ab versus gd lineage
separation process has never been investigated. Despite the
central role that ERK signaling plays in essentially every
lymphoid fate decision, the basis by which differences in ERK
signaling promote the specification of alternative cell fates re-
mains poorly understood (Raman et al., 2007).
Consequently, we have investigated the basis by which differ-
ences in ERK signaling specify alternate developmental fates,
using separation of the ab and gd lineages as a model. Diver-
gence of the ab and gd lineages is controlled by the strength
of TCR signals, with weak and strong TCR signals favoring
adoption of the ab and gd fates, respectively, irrespective of
the TCR isotype from which they originate (Hayes and Love,
2006). Indeed, we and others showed that a single gdTCR
that normally directs adoption of the gd fate can divert pro-
genitors to the ab fate when its ability to transduce signals is
attenuated (Haks et al., 2005; Hayes et al., 2005). The signaling
cascades whose graded activation is responsible for alternate
specification of the ab and gd fates remain poorly understood,
but do involve differential activation of ERK (Lauritsen et al.,
2009); however, the importance of the differences in ERK
signaling for fate choice has never been directly evaluated.
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Alternative ERK Function in gd T Cell DevelopmentHere, we report that adoption of the gd fate is dependent upon
ERK signals that are stronger and more prolonged than those
associated with commitment to the ab fate. Most surprisingly,
the stronger and more prolonged ERK signals that promote
adoption of the gd fate do not depend upon the ability of ERK
to phosphorylate conventional substrates through its D-domain,
despite the fact that approximately 80% of ERK2 substrates are
thought to be targeted through the D-domain (Carlson and
White, 2012). Instead, adoption of the gd fate depends upon
an alternative mode of ERK action that utilizes a different dock-
ing mechanism mediated by its DEF binding pocket (DBP).
Indeed, these data provide the first demonstration that the pro-
longed ERK signals that promote gd T cell fate specification
depend not on conventional substrate targeting through the
D-domain, but instead depend on an alternate mode of ERK ac-
tion mediated by its DBP, which posttranscriptionally induces
the molecular effectors responsible for execution of ERK-medi-
ated developmental outcomes.
RESULTS
Maturation of gdCells Is Dependent upon ERK Signaling
In addressing themolecular basis of ERK-mediated specification
of lymphoid fates, we focused on ab versus gd lineage commit-
ment, where graded induction of ERK activity had previously
been noted, but its importance had not been evaluated (Hayes
et al., 2005; Jensen et al., 2008). We have shown, using the
KN6 gdTCR transgenic (Tg) model, that thymic progenitors
adopt the gd fate in the presence of the KN6 selecting ligand,
H-2T10d (Lig+), but are diverted to the ab fate if TCR signaling
is attenuated by impairing ligand expression through b2M defi-
ciency (Lig) (Haks et al., 2005). KN6 progenitors adopting the
gd fate in the presence of ligand (Lig+) in vivo exhibit greater
ERK phosphorylation as measured by intracellular staining (Fig-
ure 1A). Moreover, ERK phosphorylation was also more pro-
nounced in fetal KN6 progenitors adopting the gd fate in vitro
on ligand-expressing (Lig+) OP9-DL1 stromal cells, than in those
adopting the ab fate in the absence of ligand (Lig) (Figure 1A).
ERK phosphorylation was greatest in immature CD24hi cells
and was progressively lost during maturation (see Figures S1A
and S1B available online), consistent with a recent report indi-
cating that signaling thresholds increase during maturation of
gd progenitors (Wencker et al., 2013). Collectively, these data
demonstrate that adoption of the gd fate is associated with
markedly enhanced ERK signaling.
To determine whether gd lineage commitment was dependent
upon greater ERK activity, we investigated the effect of ERK1
and ERK2 deficiency on gd T cell development. Erk2 was condi-
tionally ablated in T lineage progenitors using Ptcra-Cre (Luche
et al., 2013), while Erk1 was ablated in the germline (Fischer
et al., 2005). Ptcra-Cre-mediated ablation of Erk2 began in
DN3 (CD4CD8CD44CD25+) thymocytes and was complete
in DN4 (CD4CD8CD44CD25) and gdTCR+ thymocytes (Fig-
ure S1C). Consistent with previous reports, ablation of both Erk1
and Erk2 (ERK deficiency) reduced thymic cellularity and
impaired development of ab T cell progenitors beyond the b-se-
lection checkpoint at the DN3 stage, blocked the maturation of
CD4+CD8+ (double-positive; DP) thymocytes to the CD4+ and
CD8+ stage (Figure S1D) (Fischer et al., 2005), and abrogatedIthe development of CD1d-aGalCer reactive NKT cells (Fig-
ure S1E) (Hu et al., 2011). Moreover, ERK-deficiency reduced
the absolute number of CD24lo mature gd lineage cells, suggest-
ing that maturation of gd T cell progenitors was dependent upon
ERK signaling (Figure S2A). We further investigated the effect of
ERK deficiency on particular Vg subsets and found that ERK
deficiency reduced the number of CD24lo mature Vg1 and Vg2
progenitors in the thymus and the number of Vg3+ dendritic
epidermal T cell (DETC) in the skin (Figures S2A and S2B). Abla-
tion of either Erk1 or Erk2 alone did not affect the numbers of gd
T cells in thymus, spleen, or skin (Figures S2C–S2E). These data
demonstrate that ERK signaling is required for maturation of gd T
lineage cells in the thymus.
ERK Signaling Regulates ab versus gd T Cell Lineage
Commitment
Because elevated ERK signaling is important for gd T cell matu-
ration, we wished to determine whether attenuation of ERK
signaling resulted in a fate-switch to the ab lineage. To deter-
mine whether ERK-deficiency diverted gdTCR+ progenitors to
the ab fate as evidenced by their development to the DP stage,
we assessed the effect of ERK-deficiency on the development
of TCRb-deficient progenitors, which can express the gdTCR,
but not the pre-TCR or abTCR. ERK deficiency blocked the
maturation (i.e., CD24 downmodulation) of TCRb-deficient,
gdTCR-expressing thymocytes and impaired the induction of
CD73 among CD24hi immature progenitors (Figure 1B). We
recently demonstrated that CD73 induction marks gdTCR+
CD4CD8 (double-negative; DN) thymocytes that have
committed to the gd T cell lineage (Coffey et al., 2014). Along
with impairing gd T cell lineage commitment and maturation,
ERK deficiency also diverted TCRb-deficient gdTCR+ progeni-
tors to the ab lineage and the DP stage of development (Fig-
ure 1B). The diversion of these gdTCR+ progenitors to the ab
T cell fate in ERK-deficient mice was also associated with sub-
stantial reductions in gd T cells in the spleen (Figure 1C) and
Vg3+ DETC gd in the skin (Figure 1D). Taken together, these
data indicate that the increased ERK activity observed in cells
adopting the gd T cell fate is required for both adoption of the
gd T cell fate and for repression of the ab T cell fate. These
data also demonstrate that while ERK-deficiency abrogated
the ability of the gdTCR to repress the ab T cell lineage, ERK-
deficiency did not block the ability of the gdTCR to promote
development of progenitors beyond the b-selection checkpoint
to the DP stage.
Analysis of the effect of ERK deficiency on ab versus gd line-
age commitment using the KN6 gdTCR Tg model produced
similar results. Indeed, Rag2-deficient progenitors expressing
only the KN6 gdTCR adopt the gd fate in the presence of T10d
ligand (KN6 Tg Lig+), as evidenced by their retention of the
DN phenotype and downregulation of the maturation marker,
CD24 (Figure 1E, left panels) (Haks et al., 2005); however,
ERK-deficiency not only blocked the maturation of KN6 gdTCR
Tg progenitors developing in the presence of ligand, but it also
robustly diverted those progenitors to the ab T cell fate, as indi-
cated by their development to the DP stage (Figure 1E, right
panels). This involved striking increases in the absolute number
of ab lineage DP thymocytes, as well as reductions in the abso-
lute number of mature CD24lo gd T cells that normally develop inmmunity 41, 934–946, December 18, 2014 ª2014 Elsevier Inc. 935
Figure 1. ERK-Deficiency Diverts gd TCR-Expressing Progenitors to the ab T Cell Fate
(A) Suspensions of explanted thymocytes from KN6 Tg ligand expressing (Lig+) and ligand-deficient (Lig) mice were fixed and permeabilized, following which
phospho-ERK staining was assessed on electronically gated TCRd-positive progenitors. ERK phosphorylation and Egr1 protein expression were assessed by
immunoblotting of detergent extracts from E14.5 KN6 gd TCR Tg fetal liver progenitors cocultured for 7 days on OP9-DL1 cells expressing (Lig+) or lacking ligand
(Lig).
(B and C) Thymocytes and splenocytes from 6- to 7-week-old Ptcra-Cre-Erk1+/+Erk2fl/fl (Erk1+/+Erk2+/+) and Ptcra-Cre+Erk1/Erk2fl/fl (Erk1/Erk2/) Tcrb/
micewere analyzed by flow cytometry with the indicated antibodies. Gate frequencies of the indicated populations were used to calculate the absolute number of
thymocyte subsets, which are depicted graphically (right panels). Cumulative data shown are the means ± SEM from at three independent experiments. *p < 0.05
(legend continued on next page)
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Figure 2. Intrathymic Acquisition of Effector Function Is Altered by ERK Deficiency
(A) Functional, cluster B (CD44+CD24) gd progenitors were analyzed by flow cytometry. Themean of CD44+CD24 cluster B cells ± SEM is depicted graphically.
(B) CD27 expression by gdTCR-expressing thymocytes from Erk1+/+Erk2+/+ (blue) and Erk1/Erk2/ (red) mice was analyzed by flow cytometry. The frequency
of CD27 and CD27+ cells ± SEM is depicted graphically.
(C) DN thymocytes from Erk1+/+Erk2+/+ and Erk1/Erk2/ KN6 gdTCR Tg mice were stimulated with plate-bound anti-CD3 Ab for 24 hr, and IFN-g and IL-17
production was determined by antibody-capture ELISA. Data shown are the means ± SEM of at three independent experiments. *p < 0.05. Error bars represent
SEM. See also Figure S3.
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mature CD24lo gd T cells in ERK-deficient mice was not associ-
ated with decreased proliferation but was accompanied by
decreased survival (Figures S2F and S2G).
ERK Signaling Influences the Specification of gd
Effector Fate
Because ERK signaling plays a critical role in gd lineage
commitment, we sought to assess its role in the acquisition
of effector function, which is largely specified in the thymus
(Bonneville et al., 2010). Recent analysis indicates that thymic
gd T cells that have acquired the ability to produce the cyto-
kines, interferon-g (IFN-g) or interleukin-17 (IL-17), are found
in ‘‘cluster B,’’ which is defined as CD44hi and CD24lo (Haas
et al., 2009). As shown in Figure 2A, ERK deficiency markedly
reduced the CD44hi CD24lo cluster B population in TCRb-defi-
cient mice, suggesting that ERK signaling is required for the
acquisition of gd T cell effector function. The choice of effector
fate is purportedly influenced by TCR signal strength (Jensen
et al., 2008), with adoption of the CD27+ IFN-g-producing(D) Dendritic epidermal gd T cells were analyzed by flow cytometry on skin prep
depicting electronically gated Thy+ cells and absolute numbers of the indicated
(E) Development of Erk1+/+Erk2+/+ and Erk1/Erk2/ KN6 Tg thymocytes was as
old mice (left panels). Gate frequencies of the indicated populations were used
graphically (right panels). *p < 0.05
Error bars represent SEM. See also Figures S1 and S2.
Ifate requiring more intense signaling than the CD27 IL-17
producing effector fate (Ribot et al., 2009; Turchinovich and
Hayday, 2011). To determine whether ERK deficiency altered
effector fate choice, we analyzed CD27 expression and found
that ERK-deficiency increased the frequency of CD27 cells in
TCRb-deficient mice (Figure 2B), consistent with the notion
that weakening TCR signaling favored adoption of the IL-17-
producing effector fate (Figure 2B). Thymocytes from KN6
gdTCR Tg mice predominantly produce IFN-g when devel-
oping in the presence of ligands. ERK deficiency attenuated
the ability of KN6 Tg thymocytes to produce IFN-g, while
augmenting the production of IL-17 (Figure 2C). The addition
of IL-1 and IL-23, which is reported to enhance IL-17 produc-
tion (Ribot et al., 2009), increased both IL-17 and IFN-g pro-
duction by ERK-deficient KN6 Tg thymocytes but did not
eliminate the bias toward IL-17 production (Figure S3). Thus,
enhanced ERK signaling is not only critical for gd T cell lineage
commitment, but also regulates maturation of cells into func-
tional cluster B and influences selection of the IFN-g or IL-
17-producing fates.s from Erk1+/+Erk2+/+ and Erk1/Erk2/ Tcrb/ mice as above. Histograms
populations are depicted graphically as above (bottom panel). *p < 0.05
sessed by flow cytometry on single cell thymic suspensions from 6- to 7-week-
to calculate the absolute number of thymocytes subsets, which are depicted
mmunity 41, 934–946, December 18, 2014 ª2014 Elsevier Inc. 937
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Posttranscriptionally Induce Egr1
To determine whether the more robust ERK signaling that pro-
motes gd T cell lineage commitment and maturation is more
intense, more prolonged, or both, we removed KN6 Tg thymo-
cytes from the selecting environment in vivo where they were
adopting the ab (Lig) or gd T cell fate (Lig+) and cultured them
in suspension in vitro to assess the kinetics of decay of ERK
phosphorylation (Figure 3A). ERK phosphorylation in thymocytes
adopting the gd fate (Lig+) persisted, and even increased, over
the 60 min course of analysis (Figure 3A). Although the basis
for this increase in ERK phosphorylation remains unclear, it
might involve escape from negative regulation induced by
chronic TCR signaling in vivo. In contrast to the prolonged ERK
signaling observed in progenitors adopting the gd T cell fate,
ERK phosphorylation in thymocytes adopting the ab fate (Lig)
was both less intense and shorter in duration, as it began to
diminish after 20 min of culture (Figure 3A). These data demon-
strate that gd T cell lineage commitment is associated with
ERK signals of greater amplitude and duration, and raise the
question of how these more intense and sustained ERK signals
promote adoption of the gd T cell fate.
ERK signals of greater amplitude would be expected to result
in greater phosphorylation of conventional substrates such as
ribosomal subunit kinase (RSK), which is mediated through
the D-domain of ERK. Consistent with this expectation, RSK
phosphorylation was more pronounced in adult KN6 gdTCR Tg
thymocytes adopting the gd T cell fate in the presence of T10d
ligand and was ERK-dependent as it was diminished by ERK
deficiency (Figure 3B).
ERK is also capable of interacting with binding partners
through a distinct interface, the DBP-domain, although the rele-
vance of this mode of action to development has never been
assessed (Dimitri et al., 2005). The DBP-domain mediates inter-
actions with DEF-domain-containing targets, many of which are
encoded by IEG, and can increase their stability (Murphy and
Blenis, 2006). This mode of action has been hypothesized to un-
derlie the execution of ERK signals of increased duration (Mur-
phy and Blenis, 2006). Accordingly, the prolongation of ERK
signals associated with adoption of the gd T cell fate would be
expected to increase the stability of IEG protein products. To
test this possibility, we focused on the IEG, Egr1, since we had
previously shown that Egr proteins play an important role in gd
lineage commitment (Lauritsen et al., 2009). Quantitation of
Egr1 mRNA and protein revealed that KN6 Tg thymocytes
committing to the gd T cell fate (Lig+) expressed 2.5-fold more
Egr1 mRNA than did cells adopting the ab T cell fate, but more
than 20 times more Egr1 protein, consistent with posttranscrip-
tional control of Egr1 expression (Figure 3C) (Lee et al., 2010).
This was not due to an intrinsic difference in Lig progenitors,
because posttranscriptional accumulation of Egr1 protein also
occurred in those progenitors upon antibody stimulation (Fig-
ure S4A). Moreover, the posttranscriptional accumulation of
Egr1 protein in cells adopting the gd T cell fate is dependent
on ERK signaling, because Egr1 protein expression is markedly
reduced in ERK-deficient KN6 Tg Lig+ progenitors, despite ex-
pressing equivalent levels of Egr1mRNA (Figure 3D). The depen-
dence of Egr1 protein accumulation on ERK signaling raised the
possibility that this involved physical interaction between Egr1938 Immunity 41, 934–946, December 18, 2014 ª2014 Elsevier Inc.and active ERK. In fact, coimmunoprecipitation analysis re-
vealed that Egr1 protein was associated with ERK in KN6 Tg thy-
mocytes adopting the gd T cell fate in the presence of ligand
(Lig+), but not in cells adopting the ab fate in the absence of
ligand (Lig) (Figure 3E). Association of ERK with Egr1 was
observed in both anti-ERK and anti-Egr1 immunoprecipitates
of Lig+ thymocytes, but not in Lig thymocytes, even when
Egr1 was transgenically overexpressed (Figure 3E). To deter-
mine whether the increased Egr1 protein observed in KN6 Tg
Lig+ thymocytes resulted from increased protein stability, we
performed metabolic labeling and pulse-chase analysis. We
found that Egr1 protein was far more stable in KN6 Tg Lig+ thy-
mocytes adopting the gd T cell fate, than in KN6 Tg Lig Egr1
Tg thymocytes (Figure 3F). Global protein synthesis was un-
changed in KN6 Tg Lig+ thymocytes (Figure S4B). Taken
together, these data demonstrate that adoption of the gd T cell
fate is associated with prolonged ERK signals that lead to the
physical interaction of ERK with IEG such as Egr1, which in-
creases Egr1 protein stability.
ERK Promotes gd T Cell Development through a
Noncanonical, DBP-Mediated Mode of Action
Adoption of the gd T cell fate is promoted by ERK signals that
are more intense and prolonged, and lead to both greater phos-
phorylation of conventional substrates through the D-domain
and stabilization of IEG such as Egr1, through the DBP-domain.
To test the contribution of these two modes of ERK action to
adoption of the gd T cell fate, we mutated the ERK domains
responsible. ERK2 interaction with DEF containing targets is
mediated by the DBP domain and this can be disrupted by
the Y261A mutation (Dimitri et al., 2005). Interactions with con-
ventional substrates like RSK are mediated by the ERK2 D-
domain and can be disrupted by the D319N mutation (Dimitri
et al., 2005). To verify that these mutations had the intended ef-
fects, we expressed them in ERK-deficient fetal liver (FL) pro-
genitors, where they were phosphorylated to similar extents
upon PMA and ionomycin stimulation (Figure 4A). The D319N
D-domain mutation attenuated RSK phosphorylation by ERK2
in KN6 gdTCR+ progenitors cultured on ligand-expressing
OP9 monolayers (Figure 4B); however, it did not disrupt the
interaction of ERK2 with Egr1, as measured by coimmuno-
precipitation (Figure 4C). The Y261A DBP-domain mutation,
which disrupts interaction with DEF containing IEG targets,
only minimally affected RSK phosphorylation, but completely
blocked coprecipitation of ERK2 with Egr1 (Figures 4B and
4C). Consequently, the ERK2 D319N and Y261A mutations
had the expected effects of blocking phosphorylation of con-
ventional substrates and interaction with DEF domain-contain-
ing targets, respectively. To determine how disruption of
substrate phosphorylation and interaction with DEF domain-
containing targets affected gd T cell development, we ex-
pressed the mutant ERK2 molecules in ERK-deficient KN6
gdTCR Tg FL progenitors and assessed the effect on maturation
on OP9-DL1 monolayers expressing ligand (Figure 4D). As we
observed in intact KN6 gdTCR Tg progenitors developing in vivo,
ERK-deficiency impaired their maturation in vitro as measured
by CD24 downmodulation (Figure 4D). Retroviral reconstitution
of these cells with wild-type (WT) ERK2 restored maturation
and this was not impaired by abrogation of the ability of ERK2
Figure 3. Prolonged and More Intense ERK Signals Associated with gd T Cell Development Promote ERK-Egr1 Interactions and Increased
Egr1 Protein Stability
(A) KN6 gdTCR Tg DN thymocytes adopting the gd T cell fate (Lig+) or ab fate (Lig) were cultured in suspension and the persistence of ERK phosphorylation was
assessed by anti-phospho ERK immunoblotting of detergent extracts.
(B) The role of ligand stimulation in ERK phosphorylation of RSKwas examined in adult KN6 gdTCR Tg thymocytes developing in the presence (Lig+) or absence of
(Lig) T-10d ligand (left panels) or lacking ERK (ERK+ and ERK; right panels). RSK phosphorylation was measured by phosphoblotting.
(C and D) Egr1 protein and mRNA expression were measured by immunoblotting and real-time PCR, respectively, in KN6 Tg thymocytes adopting the gd T cell
fate (Lig+) or the ab T cell fate (Lig) in ERK-expressing (ERK+) or deficient (ERK) mice. Protein levels were quantified by measuring the fluorescence emitted by
bound anti-Egr1 antibody using the Li-COR.
(E) To assess the extent of ERK-Egr1 interaction, detergent extracts from DN of the indicated genotypes were immunoprecipitated with either anti-ERK or anti-
Egr1 following which associated proteins were detected by immunoblotting.
(F) The stability of newly synthesized Egr1 protein was measured by performing metabolic labeling for 30 min with 35S-methionine, chasing the labeled cells for
2 and 4 hr, and then immunoprecipitating Egr1 protein. The quantity of labeled Egr1 protein remaining during the chase was determined by phosphorimagery
and normalized to incorporation during the pulse (bottom panel). The data are representative of at least two independent experiments. All error bars indicate
mean ± SEM. See also Figure S4.
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D319N). However, maturation was abrogated when the altera-
tive mode of ERK action, enhancement of protein stability
through DBP-domain interactions with IEG, was attenuatedI(Figure 4D; Y261A). These results indicate that the ERK signals
that promote gd T cell maturation do not require the ability
of ERK to phosphorylate substrates like RSK, and instead
depend on a noncanonical mode of ERK function that involvesmmunity 41, 934–946, December 18, 2014 ª2014 Elsevier Inc. 939
Figure 4. ERK Interaction with DEF
Domain-Containing Targets through Its
DBP Domain Is Required for ERK to Pro-
mote gd T Cell Development
(A–C) To determine whether mutations abrogating
function of the D-domain (D319N) or DBP domain
(Y261A) of ERK2 had the intended effects, we
transduced these mutant constructs along with
WT ERK2 into progenitors of the indicated geno-
types, cultured for 7 days on OP9-DL1 cells ex-
pressing ligand, and analyzed themwithout further
treatment (B) or following stimulation with PMA
and ionomycin (A and C). The effect of mutations
on RSK phosphorylation was evaluated by phos-
phoblotting and the effect on ERK2-Egr1 associ-
ation was assessed by immunoprecipitating with
anti-ERK antibody and immunoblotting with anti-
Egr1 or anti-ERK antibodies (A–C).
(D) The effect on gd T cell development of abro-
gating ERK interaction with substrates (ERK2
D319N) or DEF domain-containing targets (ERK2
Y261A) was assessed by reconstituting ERK-
deficient KN6 gdTCR Tg progenitors with WT
or mutant ERK2 molecules and culturing them
on ligand expressing OP9-DL1 monolayers.
Following 6 days of culture, development was
monitored by flow cytometry on electronically
gated GFP+ cells. Contour plots showing TCRd
and CD24 expression are depicted. The data
are representative of at least two independent
experiments.
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ing molecules like Egr1.
To determine whether development of gd T cells in vivo was
also dependent on DBP-domain based interactions with DEF
domain containing targets, we constructed bone-marrow
chimeras transduced with the Erk2 mutants above. KN6 Tg
Rag2/Erk1/Erk2/ bone-marrow progenitors were retro-
virally transduced with WT and mutant Erk2 molecules and
transferred into lethally irradiated Rag2/ recipients (Figure 5).
Repopulation of early hematopoietic progenitors was equivalent
for all constructs (Figure S5). Consistent with the results of our
in vitro analysis with FL progenitors (Figure 4D), bone-marrow
chimeras reconstituted with ERK-deficient progenitors trans-
duced with empty vector failed to commit to the gd T cell fate
as indicated by induction of CD73 (Figure 5A, top panel) (Coffey
et al., 2014). gd T cell lineage commitment (i.e., CD73 induction)
was rescued by retroviral transduction with WT and D-domain
mutant ERK2 (D319N); however, the DBP-domain mutant
(Y261A) ERK2, which is unable to interact with DEF-domain
containing targets, failed to rescue lineage commitment (Fig-
ure 5A; top panels). The DBP-domain (Y261A) ERK2 mutant
also failed to restore maturation as indicated by CD24 downmo-
dulation (Figure 5A; middle panels) or the acquisition of function
as measured by the accumulation of the cluster B (CD44+
CD24lo) gd T cell subset (Figure 5A; bottom panels). Conversely,
the D-domain (D319N) ERK2 mutant restored both maturation
and acquisition of effector fate to the same extent as WT940 Immunity 41, 934–946, December 18, 2014 ª2014 Elsevier Inc.ERK2. Taken together, these results support the surprising
conclusion that gd T cell lineage commitment and maturation
do not depend on the ability of ERK to phosphorylate conven-
tional substrates such as RSK, through its D-domain, despite
the fact that most (80%) ERK targets are selected in this
manner. Instead gd T cell lineage commitment and maturation
are critically dependent upon an alternative mode of ERK func-
tion, physical interaction with DEF-domain-containing targets
mediated by its DBP domain. This represents the first demon-
stration of the importance of this noncanonical mode of ERK ac-
tion in lymphoid development.
Prolonged ERK Signals Facilitate Transactivation of
Targets by Egr1
Our data support a model where ERK promotes gd T cell devel-
opment through DBP-domain-mediated association with sub-
strates that increases their expression by increasing their stabil-
ity; however, it remained unclear how increasing protein stability
might promote adoption of the gd fate. One possibility is that
these interactions could stabilize IEG that function as transcrip-
tion factors, thereby enabling them to transactivate targets more
effectively than is possible following transient ERK signals. To
address this possibility, we focused on Egr1, because Egr1 is
an IEG that we have previously shown to be an important effector
of the TCR signals that promote gd T cell development (Lauritsen
et al., 2009). Egr1 modulated genes were identified by microar-
ray analysis of a thymic lymphoma in which Egr1 was ectopically
Figure 5. ERK Signals Require DBP-Mediated Interactions to Promote gd T Cell Development In Vivo
(A) Erk1/Erk2/ KN6 gdTCR Tg Rag2/ bone-marrow progenitors were retrovirally reconstituted with WT or the indicated ERK2 mutants and transferred to
Rag2/ hosts. After 7 weeks, the ability of the transduced ERK2mutant to restore gd T cell development was assessed by flow cytometry on electronically gated
GFP+ thymocytes.
(B) The frequency of TCRd+ CD24lo and TCRd+ CD73hi cells was depicted graphically, with each symbol representing an individual mouse and the horizontal line
indicating the mean. *p < 0.05. See also Figure S5.
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sion of 624 probes (Table S1). To determine whether these
targets were enriched among those modulated during gd T cell
lineage commitment, we also performed microarray analysis of
KN6 progenitors committing to the gd T cell fate in the presence
of ligand (Lig+) or to the ab fate in its absence (Lig) (Table S1).
Indeed, hypergeometric analysis revealed that more than 40%
of the Egr1 targets were found among those genes differentially
expressed during commitment to the gd T cell fate, representing
substantial enrichment (Figure 6A; p < 0.001). Moreover, these
Egr1 targets weremore significantly modulated by the prolonged
and more intense ERK signals associated with gd T cell lineage
commitment (Figure 6B; Lig+) than by the shorter and less
intense signals associated with adoption of the ab fate (Fig-
ure 6B; Lig). Thus, the promotion of gd development by ERK
signals is accompanied by the stabilization of the IEG transcrip-
tion factor Egr1, which enables it to more effectively transacti-
vate its gene targets (Figures 6 and S6). ERK-IEG interactions
might also promote alternative cell fates through actions on pro-
teins in other gene ontology classes, because adoption of the gd
fate is also linked tomodulation of DEF-domain containing genes
involved in signal transduction and metabolism, as well as other
functions (Figure 6C).IThe Alternative Mode of ERK Function Is Required for
Maturation of ab Lineage DP Thymocytes
Because graded induction of ERK activity has been implicated in
fate specification at a number of developmental checkpoints and
lineage branch points encountered by lymphocytes, we sought
to determine whether the DBP-mediated mode of ERK function
might play an important role in other developmental processes.
To do so, we employed zinc-finger nuclease (ZFN) mutagenesis
to introduce the ERK2 Y261A mutation into the endogenous
murine Erk2 locus (Figure 7A). The Erk2Y261A allele was then
crossed to a floxed Erk2 allele that was conditionally ablated in
T lineage progenitors using Ptcra-Cre. Relative to ERK2 WT
mice, ERK2 Y261A mice had equivalent thymic cellularity, but
exhibited a defect in gd T cell lineage commitment and matura-
tion, as indicated by impaired CD73 induction and CD24 down-
modulation, respectively (Figures 7B and 7C), consistent with
our observations in the bone-marrow chimera model (Figure 5).
Moreover, upon removal from the selecting milieu, immature
CD73-gdTCR+ progenitors from ERK2 Y261A mice exhibit
more extensive diversion to the ab fate, as indicated by their
development to the DP stage when cultured on OP9-DL1 mono-
layers (Figure S7). Differentiation of ab lineage thymocytes
beyond the b-selection checkpoint to the DN4 stage andmmunity 41, 934–946, December 18, 2014 ª2014 Elsevier Inc. 941
Figure 6. Egr1 Target Genes Are Preferentially Modulated during gd
T Cell Development
(A) Hypergeometric analysis was performed on Egr1-modulated genes to
determine the extent of their enrichment among the genes whose expression
was modulated during adoption of the gd fate by KN6 Tg progenitors.
(B) Microarray analysis was performed on KN6 gdTCR Tg thymocytes
adopting the gd fate in the presence of ligand (Lig+) and the ab fate
in the absence of ligand (Lig). Egr1 target genes were identified
among the differentially expressed genes and displayed as a heatmap
illustrating the relative expression of those Egr1 targets in Lig+ or Lig
thymocytes.
(C) DEF domain-containing genes that were differentially expressed in Lig+
versus Lig thymocytes were grouped based on gene ontology and displayed
Immunity
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942 Immunity 41, 934–946, December 18, 2014 ª2014 Elsevier Inc.ultimately to the DP stage was not impaired by the ERK2 Y261A
mutation (Figures 7D and 7E); however, abrogation of ERK DBP-
mediated processes by the ERK2 Y261A mutation dramatically
impaired the differentiation of ab lineage thymocytes to the
CD4+ and CD8+ single-positive (SP) stages (Figure 7E). The
impaired differentiation to the CD4+ and CD8+ SP stages was
accompanied by a block in the generation of both TCRbhi
CD69+ and TCRbhi CD69 thymocytes (Figure 7E), which are
positive selection intermediates (Yamashita et al., 1993).
Taken together, our data support a model whereby prolonged
ERK signals are required to promote gd T cell lineage commit-
ment and maturation, by supporting ERK association with and
stabilization of DEF domain-containing proteins, which modu-
lates the cellular proteome independently of changes in mRNA
levels. This alternative mode of ERK function is dispensable for
the initial commitment of pre-TCR-expressing progenitors to
the ab fate, but is required for gdTCR+ progenitors to both adopt
gd T cell fate and suppress adoption of the ab fate. Moreover, it
also plays a critical role in the more distal developmental pro-
cesses encountered by ab lineage progenitors, including their
positive selection.
DISCUSSION
ERK signaling plays a central role in many fate decisions; how-
ever, despite intensive efforts, the basis by which differences
in ERK signaling contribute to the specification of alternative
cell fates remains poorly understood (Raman et al., 2007).
Most models postulate a prominent role for differential ERK sub-
strate phosphorylation through its D domain. Here, we provide
the first evidence that the differences in ERK activity that underlie
separation of the ab and gd T cell lineages do so through a non-
canonical, alternative mode of ERK function, that involves inter-
action with DEF domain-containing substrates through its DBP
domain. In contrast, the ability of ERK to phosphorylate sub-
strates through its D-domain is dispensable for this process,
despite recent evidence indicating that most ERK substrates
are targeted in this manner (Carlson and White, 2012). DBP
domain-mediated interactions appear to impact fate-specifica-
tion posttranscriptionally by increasing the stability of DEF
domain-containing proteins. Among these are transcription fac-
tors such as Egr1, which play an important role in ab versus gd
lineage commitment. The stronger andmore prolonged ERK sig-
nals that promote adoption of the gd T cell fate increase Egr1
protein stability, thereby enabling Egr1 and likely other IEG tran-
scription factors to more effectively transactivate their targets
than is possible in response to the weaker and more transient
ERK signals associated with adoption of the ab fate.
The involvement of stronger and more prolonged ERK signals
in promoting adoption of the gd T cell fate raises the question of
how such signals are generated. Many regulators of ERK signal
intensity and duration have been identified (Andreadi et al.,
2012), such as the linkage of B-Raf to prolonged ERK activation
(Tsukamoto et al., 2004). B-Raf is thought to prolong ERKin a heatmap illustrating the differences in expression in Lig+ versus Lig
thymocytes. The genes in the heat maps are significantly differentially ex-
pressed (p < 0.0001). See also Figure S6 and Tables S1 and S2.
Figure 7. Role of ERK-DBP Interactions in Promoting Positive Selection of ab T Cells
(A) Schematic of the strategy employed to mutagenize the DBP domain of ERK2 encoded by exon 6 of the murine Erk2 locus.
(B–E) The effect of disabling the DBP domain of ERK2 on T cell development was assessed by performing flow cytometry on single cell suspensions of thy-
mocytes from Erk1+/Erk2fl/fl Ptcra-Cre- and Erk1+/Erk2Y261A/fl Ptcra-Cre+ mice. Gate frequencies of the indicated populations were used to calculate the
absolute number of thymocyte subsets, which are depicted graphically (right panels). Data shown are the means ± SEM. *p < 0.05. See also Figure S7.
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dins220, which is expressed in T lineage progenitors and associ-
ates with both the pre-TCR and gdTCR (Deswal et al., 2013). The
duration of ERK signals has also been linked to the extent of het-
erodimerization of upstream signaling molecules, MEK1 and
MEK2 (Catalanotti et al., 2009). Finally, pharmacologic inhibition
of P2X7 (ATP-gated nonselective cationic receptor) has been re-
ported to impair ERK activation, blunt Egr1 induction, and divert
gd T cell progenitors to the ab T lineage fate (Frascoli et al., 2012).IHow these regulators of ERK signaling might modulate ERK sig-
nals in the context of ab versus gd lineage commitment process
remains unclear. One possibility is that these regulators of ERK
signaling are differentially expressed in distinct progenitor pools,
and could predispose certain progenitors to adopt the gd fate.
Nevertheless, accumulating evidence suggests that the pre-
TCR and gdTCR complexes are acting instructionally to direct
uncommitted progenitors to adopt a lineage fate, rendering
this possibility less likely (Kreslavsky et al., 2008). An alternativemmunity 41, 934–946, December 18, 2014 ª2014 Elsevier Inc. 943
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either the pre-TCR or gdTCR and confer upon those receptors
the tendency to induceweak or transient and strong or sustained
ERK activation, respectively; however, none of the molecules
identified to date have been selectively linked to either TCR iso-
type. Moreover, we demonstrate here that the KN6 gdTCR is
capable of promoting either weak/transient or strong/sustained
ERK signals (Figure 3). This observation raises another possibil-
ity, that the transduction of stronger and more sustained ERK
signals by the gdTCR is dependent, at least in some cases, on
TCR ligand-engagement. Consistent with this possibility, we
recently identified a TCR-ligand inducible surface marker of gd
lineage commitment, CD73 (Coffey et al., 2014). CD73 is ex-
pressed by 25% of gdTCR+ cells in the thymus and by 90%
of peripheral gd T cells, suggesting that ligand-engagement is
extensively involved in specification of the gd T cell fate, even
among the IL-17 producing gd T cell effector subset, which
has been suggested to develop in a ligand-naive manner (Coffey
et al., 2014; Jensen et al., 2008). This is consistent with a recent
report indicating that TCR agonist stimulation plays a role in the
development of at least some subsets of IL-17 producing gd
T cell cells (Wencker et al., 2013). These authors also reported
that agonist stimulation in the thymus serves to blunt gdTCR
signaling capacity, consistent with our observation that CD24lo
mature KN6 gdTCR Tg gd cells exhibit less ERK phosphorylation
than CD24hi immature gd T cells (Figure S1) (Wencker et al.,
2013).
There has been considerable effort directed toward under-
standing how differences in ERK signaling lead to alternate
developmental outcomes. One view is that ERK signals of
differing intensity or duration might enable ERK to phosphory-
late a distinct spectrum of substrates due to trafficking of
ERK to distinct subcellular locations, such as cytosol versus
nucleus. von Kriegsheim et al. recently reported that stimulation
of PC12 cells with EGF or NGF leads to alternate fate out-
comes, and these outcomes (proliferation versus neuronal dif-
ferentiation, respectively) are associated with the targeting of
ERK to distinct subcellular locations (von Kriegsheim et al.,
2009). The differences in ERK localization were, in turn, linked
to differential association with neurofibromin 1 (NF1) and
PEA-15 (von Kriegsheim et al., 2009). NF1 is a Ras GTPase
activating protein whose loss in T cells impaired both develop-
ment and peripheral function (Ingram et al., 2002). PEA-15 as-
sociation with ERK prevents its translocation to the nucleus,
but its loss does not impair T cell development (Formstecher
et al., 2001; Pastorino et al., 2010). Other mechanisms, such
as differences in the dimerization of MEK1 and MEK2, have
also been reported to influence nuclear localization (Catalanotti
et al., 2009). Irrespective of the mechanism of altering the sub-
cellular localization of ERK, this remains an attractive mecha-
nism by which differences in the duration of ERK activity can
lead to alternate cell fates. Nevertheless, our results suggest
that at least in the context of ab versus gd lineage commitment
and in positive selection of ab lineage thymocytes, these poten-
tial differences in subcellular localization do not specify fate by
phosphorylation of substrates through the D-domain of ERK,
and instead, depend on an alternative mode of ERK action,
mediated by its interaction with DEF domain-containing targets
through its DBP domain.944 Immunity 41, 934–946, December 18, 2014 ª2014 Elsevier Inc.How might interactions between ERK and DEF domain-con-
taining proteins promote the alternate fates specified by differ-
ences in the intensity or longevity of ERK signals? The IEG
(immediate early gene) sensor hypothesis posits that prolonged
ERK signaling alters developmental outcomes bymodulating the
stability of IEG protein products (Murphy and Blenis, 2006). Spe-
cifically, irrespective of their intensity, transient ERK signals (less
than 30min) decay prior to synthesis of IEG protein products, re-
sulting in their rapid degradation. Conversely, prolonged ERK
signals (60 min or longer) are proposed to persist until IEG pro-
tein products are produced, enabling ERK to bind IEG containing
DEF-domains through its DBP domain and increase their stabil-
ity. Here, we provide the first evidence of the importance of this
mechanism in development. We propose that there are several
ways by which increasing protein stability might lead to a distinct
developmental outcome. Stabilization of IEG encoding tran-
scription factors enables those transcription factors to transacti-
vate targets to a greater extent than would be possible under
conditions where ERK signaling is transient, and we have
observed this for the targets of the zinc-finger transcription fac-
tor Egr1 (Figure 6). The prolonged ERK signals also result in more
profound repression of Egr targets than is observed in cells
adopting the ab T cell fate (Figure 6); however, the factors that
determine whether a target is induced or repressed remain to
be determined. While the prolonged ERK signals that promote
gd T cell lineage commitment clearly increased the stability
and expression of Egr1 protein, this was not the case for all
DEF-domain containing transcription factors expressed in cells
adopting the gd T cell fate. Specifically, while c-Jun protein levels
were increased disproportionately relative to its mRNA, this was
not observed for other DEF domain containing IEG, including c-
Myc, Fra-2, and c-Fos (Figure S6). The factors that determine
whether prolonged ERK signals will stabilize a particular DEF
domain-containing target protein remain poorly understood.
Thus, in order to understand the basis by which this mode of
ERK action promotes fate specification in distinct developmental
contexts, proteomic analysis must be performed to identify the
subset of ERK targets that is stabilized. Nevertheless, it is clear
that along with transcription factors, there are DEF domain-con-
taining proteins that belong to other ontologic classes (signaling,
metabolism, protein synthesis, etc.), raising the possibility that
DBP-domain-mediated interactions with DEF-domain-contain-
ing targets can influence fate by affecting essentially any cellular
process.
Our data support the surprising finding that the ability of ERK
to phosphorylate conventional substrates such as RSK through
its D-domain is dispensable for adoption of the gd T cell fate.
Instead, they reveal an unexpected dependence of this process
on a noncanonical mode of ERK action, i.e., physical interaction
with DEF domain-containing proteins mediated by the DBP
motif, which acts to markedly increase expression and stability
of target proteins. This mode of action, which had not previously
been investigated in the context of normal developmental pro-
cesses in vivo, is clearly critical for both specification of the gd
T cell fate and for positive selection of ab T cell lineage thymo-
cytes. Differential activation of ERK has also been implicated in
essentially every developmental checkpoint encountered by T
lymphocytes, (Bosselut, 2004; Herna´ndez-Hoyos et al., 2000).
These include ligand-mediated selection events that shape the
Immunity
Alternative ERK Function in gd T Cell DevelopmentTCR repertoire of ab lineage T cells, CD4+ versus CD8+ T cell
lineage commitment, and peripheral effector fate specification
(Daniels et al., 2006; Liu et al., 2013; McNeil et al., 2005; Singer
et al., 2008). Accordingly, it will be important to investigate the
mode of ERK action in these differentiation processes to assess
their dependence on the alternativemode of ERK function, which
involves its interaction with substrates through its DBP-domain.
EXPERIMENTAL PROCEDURES
Mice
All mice were maintained in Fox Chase Cancer Center’s AALAC-accredited
animal colony. KN6 gd TCR Tg, (Haks et al., 2005), Erk1/Erk2fl/fl (Fischer
et al., 2005), and Ptcra-Cre mice (Luche et al., 2013) were described previ-
ously. TCRb-deficient mice were purchased from Jackson Laboratory.
Erk1/Erk2fl/fl mice were crossed to Ptcra-Cre mice, and then to both KN6
gd TCR Tg and TCRb-deficient mice. All experiments were approved by the
Institutional Animal Care and Use Committee.
Flow Cytometry
Flow cytometry was performed on single cell suspensions as described in
Supplemental Experimental Procedures.
Coimmunoprecipitatation and Immunoblot Analysis
DN were isolated by negative selection using magnetic beads or by flow cy-
tometry and lysed with NP40 lysis buffer at 4C as described (Lauritsen
et al., 2009). Equal quantities of protein were resolved by SDS-PAGE and im-
munoblotted with the following antibodies as described (Lauritsen et al., 2009):
anti-pERK (Cell Signaling; 9106S), anti-total ERK (Cell Signaling; 9102), anti-
pRSK (Cell Signaling; 12032), anti-Egr1 (Cell Signaling; 4153) or anti-total
RSK (Cell Signaling; 8408), anti-c-Fos (Cell Signaling; 2250), anti-c-Jun (Cell
Signaling; 9165), anti-c-Myc (Cell Signaling; 9402), anti-Fra2 (Santa Cruz;
sc-604) and GAPDH (Millipore; MAB374). Fold-change values of p-ERK
were calculated using the Odyssey Imaging System (Li-Cor). For coimmuno-
precipitation analysis, NP40 extracts were immunoprecipitated with either
anti-Egr1 or anti-ERK and subjected to immunoblotting with the indicated
antibodies.
Pulse-Chase Analysis
Thymocytes were subjected to pulse-chase analysis, by labeling them for
30 min with 35S-methionine/cysteine at 1 mCi/ml in cysteine- and methio-
nine-free medium, following which the labeled cells were cultured as indicated
in medium containing a 10-fold excess of unlabeled methionine. Egr1 was iso-
lated from NP-40 extracts (anti-Egr1, Cell Signaling), resolved by SDS-PAGE,
visualized by fluorography, and quantified by Image Gauge Software.
Bone-Marrow Chimeras
Bone-marrow chimeras were constructed as described in Supplemental
Experimental Procedures.
Real-Time PCR
Expression of specific RNAs was quantified by real-time PCR as described in
Supplemental Experimental Procedures.
Cytokine Production Analysis
Single cell suspensions of thymocytes were stimulated with 5 mg/ml plate
bound anti-CD3 antibody with or without IL-1 and IL-23. Supernatants were
added to duplicate wells on the ELISA plate and were assayed for IL-17 and
IFN-g using standard sandwich ELISA protocols.
Retroviral Transduction and OP9 Culture
Development of KN6 gdTCR expressing progenitors on OP9-DL1 monolayers
was assessed as described in Supplemental Experimental Procedures.
ZFN-Mediated Mutagenesis of the Erk2 Locus
Candidate site-specific ZFN were designed for 150 bp target sequences on
each side of Erk2 exon 6 (Sigma Life Sciences). Plasmids encoding 8 candi-Idate ZFN (4 for each site) were transfected in all possible pairwise combina-
tions intomouse Neuro2A cells to identify themost active ZFN, following which
semiquantitative PCRwas used to assess relative ability of paired ZFN to intro-
duce DNA-breaks at Erk2 exon 6.mRNAs encoding validated ZFNwere gener-
ated by in vitro transcription and injected into fertilized mouse oocytes
together with a 100 bp single-strand oligonucleotide spanning the cut site
and encoding the single-codon change required to create the Y261A mutation
in exon 6. Founder animals were screened by specific PCR assay and Cel1
digestion to identify animals carrying the Y261A mutation, which was
confirmed by DNA sequencing.
Statistical Analysis
p values were analyzed from two-tailed Student’s t test. The extent of enrich-
ment of Egr targets among the genes modulated during commitment of KN6
progenitors to the gd fate was assessed using hypergeometric analysis.
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